טוען...

Continuous infusion of high‐dose ulinastatin during surgery does not improve early postoperative clinical outcomes in patients undergoing radical lung cancer surgery: A pilot study

BACKGROUND: Ulinastatin can prevent the perioperative increase in proinflammatory cytokines for lung resection surgery; however, its impact on early clinical outcomes remains unknown. METHODS: The study enrolled 108 non‐small cell lung cancer (NSCLC) patients who were randomly allocated into two gro...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Thorac Cancer
Main Authors: Zhou, Leng, Lan, Haidan, Zhou, Qinghua, Tang, Xiao Jun, Zhu, Daxing, Yue, Jianming, Liu, Bin
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley & Sons Australia, Ltd 2016
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129221/
https://ncbi.nlm.nih.gov/pubmed/27766771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12371
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!